Literature DB >> 15305324

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS.

Zheng Chen1, Tsuyoshi Nakamura.   

Abstract

This study estimated case fatality rates in Hong Kong, Singapore and Beijing using the number of new admissions, deaths and discharges by cure. To determine the relationships between the hazard for death and that for cure, a cure--death hazard plot was developed. The daily ratios of the two hazards determine the ultimate case fatality rate. The case fatality rate was approximately 18% for Hong Kong and Singapore, while the rate for Beijing exceeded 52% until 5 May, was 16% for 5-19 May, and 4%-1% after 20 May. These results show a significant difference in the case fatality rate between Beijing and other areas, which seems to have been due to the difference in treatment methods. That is, it suggests that combining traditional Chinese medicine with Western medicine is useful in the treatment of SARS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305324     DOI: 10.1002/ptr.1485

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  35 in total

1.  Estimating the case fatality rate using a constant cure-death hazard ratio.

Authors:  Zheng Chen; Kohei Akazawa; Tsuyoshi Nakamura
Journal:  Lifetime Data Anal       Date:  2009-05-21       Impact factor: 1.588

2.  Reckoning γ-Glutamyl-S-allylcysteine as a potential main protease (mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.

Authors:  Arun Parashar; Arpit Shukla; Ankush Sharma; Tapan Behl; Dweipayan Goswami; Vineet Mehta
Journal:  Drug Dev Ind Pharm       Date:  2021-06-07       Impact factor: 3.225

3.  Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.

Authors:  Ashish Prasad; Mehanathan Muthamilarasan; Manoj Prasad
Journal:  Plant Cell Rep       Date:  2020-06-19       Impact factor: 4.570

4.  Potentials of plant-based substance to inhabit and probable cure for the COVID-19.

Authors:  Israt Jahan; Ahmet Onay
Journal:  Turk J Biol       Date:  2020-06-21

Review 5.  COVID-19 pandemic: A review based on current evidence.

Authors:  Vidya M Mahalmani; Dhruv Mahendru; Ankita Semwal; Sukhmeet Kaur; Harpinder Kaur; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020-06-03       Impact factor: 1.200

Review 6.  Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives.

Authors:  Mohamed Nadjib Boukhatem; William N Setzer
Journal:  Plants (Basel)       Date:  2020-06-26

Review 7.  Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.

Authors:  Zhong Sun; Guozhong He; Ninghao Huang; Karuppiah Thilakavathy; Jonathan Chee Woei Lim; S Suresh Kumar; Chenglong Xiong
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

8.  Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2.

Authors:  A T M Rafiqul Islam; Jannatul Ferdousi; Md Shahinozzaman
Journal:  Saudi J Biol Sci       Date:  2021-07-17       Impact factor: 4.219

Review 9.  SWOT analysis and revelation in traditional Chinese medicine internationalization.

Authors:  Haitao Tang; Wenlong Huang; Jimei Ma; Li Liu
Journal:  Chin Med       Date:  2018-01-25       Impact factor: 5.455

Review 10.  The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

Authors:  Andréa D Fuzimoto; Ciro Isidoro
Journal:  J Tradit Complement Med       Date:  2020-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.